Rafael Simó Canonge Institutions of which they are part Head of group Diabetes and Metabolism Vall Hebron Institut de Recerca Email Rafael Simó Canonge Email Institutions of which they are part Head of group Diabetes and Metabolism Vall Hebron Institut de Recerca
Projects Impacto del uso de insulina en el riesgo de cáncer en pacientes con diabetes mellitus tipo 2 IP: Rafael Simó Canonge Collaborators: - Funding agency: Ministerio Sanidad Funding: 45000 Reference: EC10-338 Duration: 01/01/2011 - 31/12/2013 Intensificació IP: Rafael Simó Canonge Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 30000 Reference: INT10/331 Duration: 01/01/2011 - 31/12/2011 Neurodegeneration as an early event in the pathogenesis of diabetic netinopathy. Study of involved mechanisms and new therapeutic strategies IP: Rafael Simó Canonge Collaborators: Cristina Hernández Pascual, Patricia Bogdanov Baruj Funding agency: European Foundation for the Study of Diabetes Funding: 100000 Reference: EFSD-2010-02 Duration: 28/10/2010 - 27/04/2012 Neurodegeneración en la patogénesis de la retinopatía diabética incipiente. Estudio de los mecanismos impllicados a través de un abordaje integrado de biología de sistemas IP: Rafael Simó Canonge Collaborators: Marta García Ramírez, Dulce María Moncho Rodríguez, Ana Boixadera Espax, Marta Rosal Fontana, Miguel Angel Zapata Victori Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 181500 Reference: SAF2009-07408 Duration: 01/01/2010 - 31/12/2012 Pagination First page « Previous page ‹ … Page 11 Page 12 Current page 13 Page 14 Page 15 … Next page › Last page »
